Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma

Soft tissue sarcomas (STSs) are a rare cancer type. Almost half are unresponsive to multi‐pronged treatment and might therefore benefit from biologically targeted therapy. An emerging target is glycogen synthase kinase (GSK)3β, which is implicated in various diseases including cancer. Here, we inves...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Sci
Auteurs principaux: Abe, Kensaku, Yamamoto, Norio, Domoto, Takahiro, Bolidong, Dilireba, Hayashi, Katsuhiro, Takeuchi, Akihiko, Miwa, Shinji, Igarashi, Kentaro, Inatani, Hiroyuki, Aoki, Yu, Higuchi, Takashi, Taniguchi, Yuta, Yonezawa, Hirotaka, Araki, Yoshihiro, Aiba, Hisaki, Minamoto, Toshinari, Tsuchiya, Hiroyuki
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2019
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004542/
https://ncbi.nlm.nih.gov/pubmed/31808966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14271
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires